Cite
HARVARD Citation
Kesisoglou, F. et al. (n.d.). Suitability of a Minipig Model in Assessing Clinical Bioperformance of Matrix and Multiparticulate Extended‐Release Formulations for a BCS Class III Drug Development Candidate. Journal of pharmaceutical sciences. 103 (2), pp. 636-642. [Online].